Episode Summary
SDG #3: Ensure good health and promote well-being. Covid-19 revealed the weaknesses and inequalities in the global health care system and it’s stalled progress on challenges like maternal health and child survival. Assia Sidibe from the United Nations helps Liz and Steve explore how impact investments can support programs and companies that improve the health and well-being of those most in need. Annie Theriault and Keren Leshem share their story of venture capitalism in health care, and the need for further investment in women’s and adolescents’ care.
Episode Notes
In this episode you’ll hear about:
Good health targets in SDG #3 that range from reducing maternal mortality rates, work against AIDS and achieving universal health care coverage.
, a women s health company which develops, manufactures and commercializes innovative 3D intrauterine devices based on its patented IUB™
(Intra-Uterine Ball) platform, announced that it has completed a USA-focused funding round led by Rhia Ventures, to bring its IUB Ballerine® contraceptive and IUB SEAD™ point-of-care therapy for Abnormal Uterine Bleeding (AUB), to the US market, and to expand Phase II clinical trials for the IUB SEAD™.
OCON Healthcare completes funding round towards US market. OCON’s IUB Ballerine® is the first ever 3D spherical copper intrauterine contraceptive with a superior safety profile
OCON also appointment California-based Dr. Anula Jayasuriya to Chairwoman, an accomplished private equity and VC leader with over 30 years of business, scientific and medical expertise. I m excited to be appointed chairwoman of the OCON board, said